Health & Safety Notice

1. What CapsuLabs Reports Are For

CapsuLabs analyses indoor environmental conditions: temperature, humidity, surface measurements, simulated growth risk, and (when sampled) lab-confirmed species identification. Reports describe the building, not the people in it.

A CapsuLabs report can tell you: this surface is wet, that wall is at risk of colonisation within 30 days under the modelled scenario, this lab sample matched these species at this concentration.

A CapsuLabs report cannot tell you: your symptoms are caused by mold; this exposure level is safe for your specific health profile; this person should evacuate or be hospitalised; this medication or therapy is appropriate. Those are clinical questions that require a licensed medical professional.

2. When to See a Clinician

Consult a healthcare provider if you or anyone in the affected property is experiencing any of the following:

• Persistent cough, wheeze, shortness of breath, or chest tightness;
• Worsening of pre-existing asthma, COPD, or other respiratory conditions;
• Recurring sinus infections, nosebleeds, or persistent nasal congestion;
• Unexplained fatigue, headaches, brain-fog, or cognitive symptoms that improve when away from the property;
• Skin rashes, eye irritation, or allergy-like symptoms localised to time spent in the property;
• Any symptom in an immunocompromised person (post-transplant, on immunosuppressants, severe asthmatic, infant or elderly with comorbidities), escalate the threshold for consultation;
• Any symptom in pregnancy.

3. Practical Safety Steps

While you arrange a clinical consultation:

• Vulnerable individuals first: infants, the elderly, and immunocompromised occupants should temporarily relocate from rooms flagged as HIGH or ELEVATED risk on the report.
• Don't disturb visible growth: do not scrape, brush, vacuum, or pressure-wash visible mold yourself. Disturbance releases spores. Wait for a professional remediator.
• Containment: close doors to affected rooms; do not run the HVAC if the contaminated room shares ducting with bedrooms;
• Documentation: photograph affected areas before remediation; many insurance carriers require pre-remediation evidence.
• Drying first, cleaning later: stopping the moisture source is the priority. Cleanup of dry, dead growth is much safer than cleanup of active wet growth.

4. For Inspectors Communicating Findings to Occupants

• Describe what was measured. Do not describe what it means medically.
• If asked "is this making me sick?", the correct response is to refer the occupant to their physician with the report data, not to opine.
• Mycotoxin chemotypes listed in the species profile are descriptive (research literature) and not a clinical diagnosis. Do not characterise an occupant as "exposed to satratoxin" in writing or verbally.
• If the lab section flags Class-A water-damage indicators (Stachybotrys, Chaetomium, Aspergillus versicolor) at amplified concentrations, encourage the occupant to consult a clinician with a copy of the report.